Key statistics
On Monday, Can Fite Biopharma Ltd (CANF:ASQ) closed at 4.86, 44.82% above the 52 week low of 3.36 set on Dec 29, 2025.
52-week range
| Open | 4.51 |
|---|---|
| High | 4.95 |
| Low | 4.51 |
| Bid | 4.50 |
| Offer | 4.86 |
| Previous close | 4.75 |
| Average volume | 22.15k |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Announcements
- Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
- Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
- Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson
- Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
- Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction
- Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
- Can-Fite Provides Update on Clinical and Financial Status
- Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
- Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
- Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil
More ▼
